title: Giant cell hepatitis and immune thrombocytopenic purpura:  reversal of liver failure with rituximab therapy.
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA.
authors.forename: Darla
authors.initials: D
authors.lastname: Shores
authors.forename: Gregory
authors.initials: G
authors.lastname: Kobak
authors.forename: Linda D
authors.initials: LD
authors.lastname: Pegram
authors.forename: Peter F
authors.initials: PF
authors.lastname: Whitington
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Shneider
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D015726:Giant Cells / Q000276:immunology*; D019693:Hepatitis, Autoimmune / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007223:Infant; D017093:Liver Failure / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab